Novel BACE1 inhibitors with a non-acidic heterocycle at the P1′ position

Bioorganic & Medicinal Chemistry
2013.0

Abstract

We have reported potent peptidic and non-peptidic BACE1 inhibitors with a hydroxymethylcarbonyl (HMC) isostere as a substrate transition-state mimic. However, our potent inhibitors possess a tetrazole ring at the P1' position. It is desirable that central nervous system (CNS) drugs do not possess an acidic moiety. In this study, we synthesized non-acidic BACE1 inhibitors with heterocyclic derivatives at the P1' position. KMI-1764 (27) exhibited potent inhibitory activity (IC50=27nM). Interestingly, these non-acidic inhibitors tended to follow the quantitative structure-activity relationship (QSAR) equation and interacted with BACE1-Arg235 in the binding model.

DOI： 10.1016/j.bmc.2013.08.016

Knowledge Graph

Similar Paper

Novel BACE1 inhibitors with a non-acidic heterocycle at the P1′ position
Bioorganic & Medicinal Chemistry 2013.0
Novel non-peptidic and small-sized BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors
Bioorganic & Medicinal Chemistry 2015.0
4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: Synthesis, biological evaluation and docking studies
European Journal of Medicinal Chemistry 2014.0
Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Triazole-linked reduced amide isosteres: An approach for the fragment-based drug discovery of anti-Alzheimer’s BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents
ACS Medicinal Chemistry Letters 2016.0
The evolution of amidine-based brain penetrant BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease
European Journal of Medicinal Chemistry 2017.0
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraints
Bioorganic & Medicinal Chemistry 2020.0